Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-11

FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for hydroxychloroquine sulfate submitted by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine sulfate (Hydroxychloroquine sulfate)

Snippet

SUPPL AP for HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE)